RxDoctor Payments Data

Natalia Buron

Nurse Practitioner · Chicago, ILNPI 1508436502

Payments from drug & device makers

$1,060in general payments, 2019–2025

Across 43 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$290
  • Exact Sciences$122
  • Otsuka America Pharmaceutical, Inc.$111
  • Teva Pharmaceuticals USA, Inc.$93
  • Novo Nordisk$63
  • AbbVie$55
  • plus $326 from 9 others

What the payments were for

  • Food & beverage$1,060100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,060 in reported general payments places this provider in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$113,369
Medicare patients
306
Services billed
1,301

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$40,793
FarxigaDapagliflozin Propanediol43$25,644
OzempicSemaglutide22$22,808
EntrestoSacubitril/Valsartan42$19,985
JanuviaSitagliptin Phosphate12$6,807
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$1,831
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc15$1,651
Levothyroxine Sodium108$1,609
Lacosamide11$1,592
Memantine Hcl63$1,297
Sertraline Hcl61$1,154
Atorvastatin Calcium77$1,118
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen47$913
Lisinopril72$896
Potassium Chloride63$861

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$47$40,793110 claims
AstraZenecaFarxiga$290$25,64443 claims
Novo NordiskOzempic$63$22,80822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →